Congress Asset Management Co. Acquires 3,931 Shares of Intuitive Surgical, Inc. $ISRG

Congress Asset Management Co. boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 319,486 shares of the medical equipment provider’s stock after acquiring an additional 3,931 shares during the quarter. Intuitive Surgical accounts for 0.9% of Congress Asset Management Co.’s portfolio, making the stock its 28th biggest holding. Congress Asset Management Co. owned about 0.09% of Intuitive Surgical worth $142,884,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Aaron Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after purchasing an additional 19 shares during the period. Evergreen Capital Management LLC lifted its holdings in Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after buying an additional 20 shares in the last quarter. Rise Advisors LLC lifted its holdings in Intuitive Surgical by 5.6% during the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after buying an additional 20 shares in the last quarter. Pinnacle Bancorp Inc. boosted its position in Intuitive Surgical by 4.1% in the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock valued at $289,000 after buying an additional 21 shares during the period. Finally, Vertex Planning Partners LLC grew its stake in Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after acquiring an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CEO David J. Rosa sold 24,500 shares of the firm’s stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares in the company, valued at $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Henry L. Charlton sold 13,731 shares of the company’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total value of $7,963,980.00. Following the transaction, the executive vice president directly owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by corporate insiders.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Truist raised its price target to $650 and maintains a Buy rating — the upgrade gives visible upside and likely underpins analyst-driven buying interest. Read More. Read More.
• Positive Sentiment: RBC publishes a bullish forecast and RBC Capital keeps an Outperform rating — another large broker calling for strong price appreciation, supporting momentum. Read More. Read More.
• Positive Sentiment: Robert W. Baird reaffirmed its Buy rating — adds to the cluster of brokerages staying constructive, which can sustain inflows. Read More.
• Positive Sentiment: ISRG received a mention on CNBC’s “Final Trades” — media highlights can drive short-term retail/intraday interest. Read More.
• Neutral Sentiment: Company reorganized its digital and AI leadership (effective Jan 1) — signals focus on software/AI strategy but execution and timing are uncertain. Read More.
• Neutral Sentiment: ISRG plans to move to direct distribution in Southern Europe in 2026 to capture distributor economics — could lift margins if executed well, but the analyst note flags execution risk. Read More.
• Neutral Sentiment: Analyst consensus remains a “Moderate Buy” across brokerages — broad support, but not unanimous conviction; reinforces the view of steady analyst backing. Read More.
• Negative Sentiment: Valuation questions after a ~27% three‑month share-price climb — coverage is asking whether ISRG is still undervalued, raising the risk of short-term profit-taking given elevated multiples. Read More.

Intuitive Surgical Trading Up 1.9%

ISRG opened at $572.47 on Friday. The firm has a market cap of $205.22 billion, a price-to-earnings ratio of 75.72, a PEG ratio of 5.26 and a beta of 1.68. Intuitive Surgical, Inc. has a 12 month low of $425.00 and a 12 month high of $616.00. The stock has a fifty day moving average price of $541.48 and a 200-day moving average price of $505.98.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s quarterly revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.84 earnings per share. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Analyst Ratings Changes

A number of brokerages have recently commented on ISRG. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. The Goldman Sachs Group upped their target price on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, Wall Street Zen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $611.08.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.